We are live on ! Find out more
KXA

KPCB XIV Associates Portfolio holdings

AUM $42.8M
1-Year Est. Return 16.52%
This Fund
S&P 500
This Quarter Est. Return
-26.9%
1 Year Est. Return
-16.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.77M
AUM Growth
-$2.86M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OYST
1
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$7.77M 100%
367,987
– –

Similar funds

SIP
Scott Investment Partners Henley-On-Thames, United Kingdom $43.5M AUM 17.97% 1-Year Est. Return
AMC
Avenir Management Company New York $43.8M AUM 101.91% 1-Year Est. Return
OMC
OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return
JMF
Johnson Midwest Financial Glidden, Iowa $44.7M AUM 21.66% 1-Year Est. Return
MAM
Must Asset Management Seoul, South Korea $40.9M AUM 22.53% 1-Year Est. Return
HCM
Hawkeye Capital Management Miami Beach, Florida $40.6M AUM 11.3% 1-Year Est. Return
MCAV
Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return
ZAM
Zeal Asset Management Central, Hong Kong $39.4M AUM 38.83% 1-Year Est. Return

KPCB XIV Associates's Q3 2020 Portfolio in Review

As of Q3 2020, KPCB XIV Associates held 1 position worth $7.77M, down 27% from $10.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2020: portfolio turnover was 0%. KPCB XIV Associates opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • KPCB XIV Associates's ten largest holdings make up 100% of its $7.77M portfolio in Q3 2020.
  • KPCB XIV Associates opened 0 new positions and closed 0 in Q3 2020.
  • KPCB XIV Associates's portfolio value fell 27% quarter-over-quarter to $7.77M.

Based on KPCB XIV Associates's 13F filing for Q3 2020, filed 20 Oct 2020.